VBL Therapeutics (Nasdaq:VBLT) Alternatives & Competitors

12 companies similar to VBL Therapeutics (Nasdaq:VBLT) — Engineering the future of targeted medicines, breaking barriers to develop the n...

Mysthera Therapeutics

Multilineage immune modulation. The next chapter in autoimmune diseases.

3 Seed $3.50M

Basel, Switzerland

Health Care Health and Wellness

InflaRx

Controlling Inflammation - developing drugs to treat life threatening and chronic inflamma...

46 Post-IPO Equity $250.20M

Jena, Germany

Health Care Health and Wellness +1

Q32 Bio Inc.

Revolutionizing the future of targeted immune therapeutics

28 $255.50M

Waltham, United States

Biotechnology Health Care +1

Apitope

Develops drugs for treatments of allergic diseases

1 Series B $22.00M

Diepenbeek, Belgium

Biotechnology Health Care

Track all VBL Therapeutics (Nasdaq:VBLT) competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Molecular Templates

Engineering the Next Generation of Therapeutics

26 Post-IPO Equity $372.65M

Austin, United States

Biotechnology Health Care +1

Sensei Bio

We follow the immune system’s teachings to discover new treatments that inspire the body t...

32 Series B $58.50M

Rockville, United States

Biotechnology Health Care +2

Akari Therapeutics, Plc

Advancing Next-Generation Antibody Drug Conjugates Designed with Novel ImmunoOncology Payl...

17 Post-IPO Equity $114.25M

London, United Kingdom

Biopharma Biotechnology +2

Implicit Bioscience

Implicit Bioscience is developing groundbreaking immunotherapy treatments for serious, oft...

12 Venture round $17.03M

Australia

Biotechnology Health Care

SAB BIO

Working to transform treatment for people living with type 1 diabetes through a unique dis...

88 Post-IPO Equity $186.32M

Miami, United States

Biotechnology Health and Wellness

Reviva Pharmaceuticals

Next Generation Therapeutics to successfully address central nervous system, metabolic and...

18 Post-IPO Equity

Cupertino, United States

Biopharma Biotechnology +2

A2 Biotherapeutics, Inc.

Powerful & precise T cell therapy that attacks solid tumors while sparing normal cells.

138 Series B $190.50M

Agoura Hills, United Stat...

Biotechnology Health Care

Entero Therapeutics (Nasdaq: ENTO)

A biopharma company focused on the development of targeted, non-systemic therapies for gas...

12 Post-IPO Equity

Boca Raton, United States

Biotechnology Health Care +1

About VBL Therapeutics (Nasdaq:VBLT)

VBL Therapeutics (Nasdaq: VBLT) is revolutionizing the development of targeted medicines to address immune-inflammatory diseases. The company's lead product candidate, VB-601, is a promising targeted antibody designed for immune-inflammatory applications and is on track to enter Phase 1 trials this year. Clinical data...

Business keywords

Biotech, Pharma, Immunology, Therapeutics, Drug Development, Clinical-stage, Cancer, Inflammatory Diseases, Targeted Therapies, Antibody Therapy, Immunotherapy, Preclinical Research, Genetic Regulatory Elements, Disease-modifying

Frequently Asked Questions

Companies similar to VBL Therapeutics (Nasdaq:VBLT) include Mysthera Therapeutics, InflaRx, Q32 Bio Inc., Apitope, Molecular Templates. They work in Biotechnology and Health Care and share VBL Therapeutics (Nasdaq:VBLT)'s focus on immunotherapy, clinical-stage and drug development.

Bounce Watch lists 12 companies that share VBL Therapeutics (Nasdaq:VBLT)'s industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches VBL Therapeutics (Nasdaq:VBLT) and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

VBL Therapeutics (Nasdaq:VBLT) Profile Mysthera Therapeutics Alternatives InflaRx Alternatives Q32 Bio Inc. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at VBL Therapeutics (Nasdaq:VBLT) on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 10 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.